PATENT CLAIM ANALYSIS

Application Number: 16449048
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["514", "217000"]

Abstract:
The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure to eslicarbazepine in a patient. The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.

Claim (Index 45):
The method of  claim 39 , wherein the at least one other anti-epileptic drug is lamotrigine.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 100.0
- Lexical Diversity: 2.20588
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16449057', '14134843', '14240847', '13387538', '15191068']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.727731091918873
- 35 USC 102 Novelty (BERT): 0.5711939459462845
- Combined Prediction Score: 0.7120773773216141
- Mean Citation Score: 347.55288600000006
- Max Citation Score: 569.4841
- Similarity Product: 345.3864209113956

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test